NMPA Approves Shenzhen Mindray's Innovative Dual-Mode Ultrasound Diagnostic System

NMPA Approves Shenzhen Mindray’s Innovative Dual-Mode Ultrasound Diagnostic System

The National Medical Products Administration (NMPA) has granted approval to Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) for its innovative ultrasound diagnostic system, as announced on the bureau’s website.

Introducing the First Dual-Mode Imaging Product in China
The approved product is hailed as China’s first dual-mode imaging product, integrating both ultrasound and photoacoustic imaging technology. This cutting-edge system has the capability to simultaneously display ultrasound tissue structure images and photoacoustic images within a single imaging cycle. This dual-mode functionality provides medical professionals with a comprehensive view of tissue structure and functional information, enhancing diagnostic accuracy for patient conditions.

Enhancing Clinical Diagnostic Capabilities
The new system is suitable for a wide range of clinical applications, including both ultrasound and photoacoustic diagnostic examinations. The integration of these two imaging technologies allows for a more detailed and nuanced understanding of tissue characteristics, potentially leading to improved patient outcomes through more precise diagnoses.-Fineline Info & Tech

Insight, China's Pharmaceutical Industry